Abstract: The current automatic speech recognition (ASR) technology has achieved remarkable success, but it is vulnerable to adversarial attacks. To solve the problem that existing adversarial attack ...
Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional approval filing for Hydronidone and priority review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback